Source: Annual Congress 2003 - Pharmacological treatment strategies in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Corvaja, F. Andò, G. Girbino, E. Corvaja (Messina, Italy). Efficacy and effectiveness in long-term treatment with different ”new[dcdquote] drug's associations in cold patients. Eur Respir J 2003; 22: Suppl. 45, 447

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 Does short-term treatment intensification influence long-term treatment effects on health status in COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Evaluation of prophylactic observations efficacy and the quality of TB treatment using a math model for primarily revealed patients Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 The influence of the patients‘ participation in trials on the adherence to treatment in future Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Long-term effectiveness of surgery treatment of TB patients Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD) Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Evaluation of treatment with fixed dose combinations in asthma patients in primary care in Sweden by using mannitol challenge test Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Comparison of efficacy and safety of fixed-dose combination regimen versus separate drugs for treatment of tuberculosis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Relationship between prior triple therapy use and benefits of budesonide/glycopyrronium/formoterol on exacerbation risk: analysis from ETHOS Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 A long-term (2 years) efficacy and safety study of doxofylline in the treatment of asthma Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Comparative clinical-functional effectiveness and cardiological safety of short-acting combined broncholytics in 2 months basic therapy in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007 Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Predicting outcomes and drug resistance with new standardised treatment Source: Eur Respir J 2011; 37: 974 Year: 2011 One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy Source: Eur Respir J 2004; 24: Suppl. 48, 618s Year: 2004